期刊文献+

他扎罗汀诱导前后角质形成细胞TIG 3 mRNA表达 被引量:1

Effects of Tazarotene on the Expression of Tazarotene-induced Gene 3 mRNA in Normal Human Keratinocytes
下载PDF
导出
摘要 目的研究他扎罗汀对培养的正常人角质形成细胞增殖和他扎罗汀诱导基因3(TIG3)mRNA表达的影响。方法用0.1和1.0μmol/L他扎罗汀处理正常人角质形成细胞24h后,用MTT法、RT-PCR和实时定量RT-PCR(TaqMan探针)法分别检测细胞增殖和TIG3mRNA表达的改变。结果他扎罗汀可抑制角质形成的增殖和诱导TIG3mRNA的表达。0.1和1.0μmol/L他扎罗汀处理角质形成细胞后,分别使角质形成细胞增殖抑制5.0%和11.1%,使TIG3mRNA增加到正常对照组的2.1倍和2.8倍。结论他扎罗汀可抑制角质形成细胞的增殖和上调TIG3mRNA的表达。 Objective To investigate the alteration of cell proliferation and tazarotene-induced gene 3 (TIG3) mRNA expression in cultured normal human keratinocytes after tazarotene treatment. Methods After 24-hour incubation with 0. 1 and 1 μmol/L tazarotene of normal human keratinocytes, the proliferation potency of the cells was detected by MTT colorimetric assay and the expression of TIG3 mRNA was examined by reverse transcription polymerase chain reaction (RT-PCR) and real-time quantitative RT-PCR (TaqMan). Results After treatment with 0.1 and 1 μmol/L tazarotene,keratinocytes proliferation was inhibited by 5.0% and 11.1%, and TIG3 mRNA expression was induced by 2.1- and 2.8-fold, respectively. Conclusion Tazarotene can in- hibit keratinocytes proliferation and elevate TIG3 mRNA expression.
出处 《中国皮肤性病学杂志》 CAS 北大核心 2007年第8期449-451,共3页 The Chinese Journal of Dermatovenereology
基金 国家自然科学基金资助项目(No30371295 30400387) 陕西省自然科学基金资助项目(No2004C211)
关键词 角质形成细胞 他扎罗汀 他扎罗汀诱导基因 Keratinocyte Tazarotene Tazarotene-induced gene
  • 相关文献

参考文献7

  • 1Duvic M,Nagpal S,Asano AT,et al.Molecular mechanisms of tazarotene action in psoriasis[J].J Am Acad Dermatol,1997,37 (2):18-24.
  • 2张锡宝,彭振辉,曹振平.MTX对正常人表皮角质形成细胞体外培养增殖的作用及影响[J].中国皮肤性病学杂志,2003,17(6):371-373. 被引量:36
  • 3Livak KJ,Schmittgen TD.Analysis of relative gene expression data using real-time quantitative PCR and the 2^-△△CT method[J].Methods,2001,25(4):402 -408.
  • 4张江安,谭升顺,张秉正.他扎罗汀(乙炔维甲酸)的研究进展[J].中国皮肤性病学杂志,2001,15(3):200-202. 被引量:23
  • 5Duvic M,Helekar B,Schulz C,et al.Expression of a retinoid-inducible tumor suppressor,Tazarotene-inducible gene-3,is decreased in psoriasis and skin cancer[J].Clin Cancer Res,2000,6(8):3249 -3259.
  • 6Duvic M,Ni X,Talpur R,et al.Tazarotene-induced gene 3 is suppressed in basal cell carcinomas and reversed in vivo by tazarotene application[J].J Invest Dermatol,2003,121 (4):902-909.
  • 7DiSepio D,Ghosn C,Eckert RL,et al.Identification and characterization of a retinoid-induced class Ⅱ tumor suppressor/growth regulatory gene[J].Proc Natl Acad Sci USA,1998,95(25):14811-14815.

二级参考文献22

  • 1张锡宝 何玉清 吴志华 等.银屑病患者外周血CD4+T细胞内INF-a,IL-4的表达与发病的关系[J].中华皮肤科杂志,2002,35(3):155-157.
  • 2[1]Disepio D,Malhotra M,Chandraratna RA,et al.Retinoic acid receptor-nuclear factorinterleukin 6 antagonism.A novel mechanism of retinoid-dependent inhibition of a keratinocyte hyperproliferative differentiation marker[J].J Bioel Chem,1997,272:2555
  • 3[2]Duvic M,Nagpal S,Asano AT,ct al.Molecular mechanisms of tazarotene action in psoriasis[J].J Am Acad Dermatol,1997,37:s18~s24
  • 4[3]Kashihara-Sawami M,Norris AD.The state of differentiation of cultured human keratinocytes determines the level of intercellular adhesion molecule1(ICAM-1) Expression induced by γ interferon[J].J Invest Dermatol,1992,98:741~747
  • 5[4]Nagpal S,Patel S,Asano AT,et al.Tazarotene-incluced genel(TIG1),a novel retinoic acid receptor-responsive gene in skin[J].J Invest Dermatol,1996,106:269~274
  • 6[5]Nagpal S,Patel S,Jacobe H,et al.Tazarotene-induced gene2(TIG2),a novel retinoid-responsive gene in skin[J].J Invest Dermatol,1997,109:91~95
  • 7[6]Disepio D,Ghosn C,Eckert RL,et al.Identification and characterization of a retinoidinduced class Ⅱ tumor suppressor/growth regulatory gene[J].Proc Natl Acad Sci USA,1998,95:14811~14815
  • 8[7]Virtanen M,Torma H,Vahlquist A.Keratin 4 upregulation by retinoic acid in vivo:A sensitive marker for retinoid bioactivity in human epidermis[J].J Invest Dermatol,2000,114:487~493
  • 9[8]Tang-Liu DD,Matsumoto RM,Usansky JI.Clinical Pharmacokinetics and drug metabolism of tazarotene:a novel topical treatment for acne and psoriasis[J].Clin Pharmacokinet,1999,37:273~287
  • 10[9]Marks R.Pharmacokinetics and safety review of tazarotene[J].J Am Acad Dermatol,1998,39:S134~138

共引文献57

同被引文献3

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部